-
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts
Source: Buzz FX / 13 Mar 2025 02:31:17 America/Chicago
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Shares of Fate Therapeutics, Inc.
Read more...